Overview

The Effect of Z-338 in Subjects With Functional Dyspepsia

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
Z-338; PhaseIIb, Single-centre, Randomized, Double-blind, Placebo-controlled, Parallel group study in Subjects with Functional Dyspepsia, evaluate the motility of gastro-duodenum by ultrasound
Phase:
Phase 2
Details
Lead Sponsor:
Zeria Pharmaceutical
Treatments:
Z 338